Deuterium Capital Management, LLC Seagen Inc. Transaction History

Deuterium Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$191.51 - $216.16 $191,510 - $216,160	1,000 New	1,000 $212,000
Q2 2022 Jul 27, 2022	SELL	$108.81 - $179.33 $1.71 Million - $2.82 Million	-15,750 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $269,122 - $355,162	-2,250 Reduced 12.5%	15,750 $2.27 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $2.57 Million - $3.44 Million	18,000 New	18,000 $2.78 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Deuterium Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Deuterium Capital Management, LLC with notifications on news.